Literature DB >> 3202409

Clinical features and outcome in patients with acute asthma presenting with hypercapnia.

R D Mountain1, S A Sahn.   

Abstract

To determine the clinical features and outcome of patients with hypercapnia from acute asthma, we examined 229 (62 men, 167 women) consecutive episodes of acute asthma over a 6-yr period. Sixty-one episodes were associated with hypercapnia at presentation (PaCO2 greater than 38 mm Hg). Men more commonly presented with hypercapnia: 31 of 62 (50%) men with acute asthma had hypercapnia compared with only 30 of 167 (18%) women (p less than 0.001). Patients with hypercapnia had a longer duration of chronic asthma and were more likely to be steroid-dependent. Hypercapnic patients had greater airway obstruction, respiratory rate, and pulsus paradoxus than did nonhypercapnic patients. Findings of a quiet chest on auscultation, inability to talk, and cyanosis also suggested the presence of hypercapnia. Five hypercapnic patients required mechanical ventilation, but hypercapnia did not prolong hospitalization. In nonventilated patients, hypercapnia resolved in a mean time of 5.9 h; 50% of hypercapnic episodes resolved by 4 h, and all resolved by 16 h. No patient presenting with normocapnia progressed to hypercapnia with therapy, and there were no deaths in either the hypercapnic group or the nonhypercapnic group. In patients with more than one admission, the PaCO2 of one episode correlated with the PaCO2 on a subsequent admission, suggesting a role for individual variation in ventilatory control. With appropriate medical therapy, most patients with hypercapnia from acute asthma have rapid reversibility, and mechanical ventilation usually can be avoided. However, these patients require close inhospital observation until it is certain that the acute asthmatic episode has resolved.

Entities:  

Mesh:

Year:  1988        PMID: 3202409     DOI: 10.1164/ajrccm/138.3.535

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  21 in total

Review 1.  Severe acute asthma.

Authors:  S Salmeron; M Bard; F X Blanc; A Ellrodt
Journal:  Clin Rev Allergy Immunol       Date:  1999       Impact factor: 8.667

Review 2.  Status asthmaticus. From the emergency department to the intensive care unit.

Authors:  N Kenyon; T E Albertson
Journal:  Clin Rev Allergy Immunol       Date:  2001-06       Impact factor: 8.667

Review 3.  Mechanical ventilation in severe asthma.

Authors:  M Afzal; R S Tharratt
Journal:  Clin Rev Allergy Immunol       Date:  2001-06       Impact factor: 8.667

Review 4.  Overcoming gaps in the management of asthma in older patients: new insights.

Authors:  Pranoy Barua; M Sinead O'Mahony
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

5.  Management of acute asthma in adults in the emergency department: assisted ventilation.

Authors:  Rick Hodder; M Diane Lougheed; J Mark FitzGerald; Brian H Rowe; Alan G Kaplan; R Andrew McIvor
Journal:  CMAJ       Date:  2009-11-09       Impact factor: 8.262

Review 6.  Management of acute asthma in adults in the emergency department: nonventilatory management.

Authors:  Rick Hodder; M Diane Lougheed; Brian H Rowe; J Mark FitzGerald; Alan G Kaplan; R Andrew McIvor
Journal:  CMAJ       Date:  2009-10-26       Impact factor: 8.262

Review 7.  The critically ill asthmatic--from ICU to discharge.

Authors:  Samuel Louie; Brian M Morrissey; Nicholas J Kenyon; Timothy E Albertson; Mark Avdalovic
Journal:  Clin Rev Allergy Immunol       Date:  2012-08       Impact factor: 8.667

Review 8.  Critical asthma syndrome in the ICU.

Authors:  Michael Schivo; Chinh Phan; Samuel Louie; Richart W Harper
Journal:  Clin Rev Allergy Immunol       Date:  2015-02       Impact factor: 8.667

Review 9.  Perception, personality, and respiratory control in life-threatening asthma.

Authors:  G J Gibson
Journal:  Thorax       Date:  1995-09       Impact factor: 9.139

10.  Demographic characteristics of patients with severe life threatening asthma: comparison with asthma deaths.

Authors:  G N Richards; J Kolbe; J Fenwick; H H Rea
Journal:  Thorax       Date:  1993-11       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.